The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma. The U.S. Food and Drug Administration (FDA) has ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025. The FDA granted priority review to a supplemental new ...

Following our stories about the state's best new restaurants and a local island named among the world's top travel destinations, the USA TODAY NETWORK-Florida Dining and Entertainment Team now ...

Before joining Raw Story, Brad Reed spent eight years writing about technology at BGR.com and Network World. Prior to that, he wrote freelance stories for political publications such as AlterNet ...